DE60229296D1 - Verfahren zur diagnose von krebserkrankungen durch messung der mit der tumorbildung und metastase in zusammenhang stehenden änderungen der glykosylierung von prostate-derived factor (pdf). - Google Patents

Verfahren zur diagnose von krebserkrankungen durch messung der mit der tumorbildung und metastase in zusammenhang stehenden änderungen der glykosylierung von prostate-derived factor (pdf).

Info

Publication number
DE60229296D1
DE60229296D1 DE60229296T DE60229296T DE60229296D1 DE 60229296 D1 DE60229296 D1 DE 60229296D1 DE 60229296 T DE60229296 T DE 60229296T DE 60229296 T DE60229296 T DE 60229296T DE 60229296 D1 DE60229296 D1 DE 60229296D1
Authority
DE
Germany
Prior art keywords
diagnosis
measuring
changes
metastase
globalization
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60229296T
Other languages
English (en)
Inventor
Jeong Heon Ko
Soo Young Hwang
Hosung Sohn
Sejeong Oh
Jeong Hwa Lee
Sang Chul Lee
Jong-Shin Yoo
Dae-Sil Lee
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Korea Research Institute of Bioscience and Biotechnology KRIBB
Original Assignee
Korea Research Institute of Bioscience and Biotechnology KRIBB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Korea Research Institute of Bioscience and Biotechnology KRIBB filed Critical Korea Research Institute of Bioscience and Biotechnology KRIBB
Application granted granted Critical
Publication of DE60229296D1 publication Critical patent/DE60229296D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57469—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving tumor associated glycolinkage, i.e. TAG

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Oncology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
DE60229296T 2001-12-29 2002-12-28 Verfahren zur diagnose von krebserkrankungen durch messung der mit der tumorbildung und metastase in zusammenhang stehenden änderungen der glykosylierung von prostate-derived factor (pdf). Expired - Lifetime DE60229296D1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR20010088090A KR100475642B1 (ko) 2001-12-29 2001-12-29 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
PCT/KR2002/002469 WO2003060522A1 (en) 2001-12-29 2002-12-28 Method for the diagnosis of cancers by measuring the changes of glycosylation of proteins related to tumorigenesis and metastasis and kit for diagnosis of cancers using the same

Publications (1)

Publication Number Publication Date
DE60229296D1 true DE60229296D1 (de) 2008-11-20

Family

ID=19717907

Family Applications (2)

Application Number Title Priority Date Filing Date
DE60239089T Expired - Lifetime DE60239089D1 (de) 2001-12-29 2002-12-28 Verfahren zur Diagnose von Krebserkrankungen durch Messung der TIMP-1-Glycosylationsveränderungen im Zusammenhang mit der Tumorgenese und Metastasen
DE60229296T Expired - Lifetime DE60229296D1 (de) 2001-12-29 2002-12-28 Verfahren zur diagnose von krebserkrankungen durch messung der mit der tumorbildung und metastase in zusammenhang stehenden änderungen der glykosylierung von prostate-derived factor (pdf).

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE60239089T Expired - Lifetime DE60239089D1 (de) 2001-12-29 2002-12-28 Verfahren zur Diagnose von Krebserkrankungen durch Messung der TIMP-1-Glycosylationsveränderungen im Zusammenhang mit der Tumorgenese und Metastasen

Country Status (9)

Country Link
US (2) US7622261B2 (de)
EP (2) EP1972939B1 (de)
JP (2) JP4184282B2 (de)
KR (1) KR100475642B1 (de)
CN (1) CN100451655C (de)
AT (2) ATE497170T1 (de)
AU (1) AU2002359058B2 (de)
DE (2) DE60239089D1 (de)
WO (1) WO2003060522A1 (de)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7374886B2 (en) 1999-04-09 2008-05-20 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (TIMP-1) as a cancer marker and postoperative marker for minimal residual disease or recurrent disease in patients with a prior history of cancer
CA2652131A1 (en) 1999-04-09 2000-10-19 Rigshospitalet Tissue inhibitor of matrix metalloproteinases type-1 (timp-1) as a cancer marker
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트
KR100679666B1 (ko) * 2004-01-20 2007-02-07 한국생명공학연구원 인간 대식세포 억제 사이토카인-1 특이적 단일클론항체,이를 분비하는 하이브리도마 및 이를 포함하는 위암 진단키트
US7838634B2 (en) 2005-04-15 2010-11-23 Van Andel Research Institute Methods for measuring glycan levels of proteins
US8632983B2 (en) 2005-04-15 2014-01-21 Van Andel Research Institute Biomarkers for pancreatic cancer and diagnostic methods
KR100721507B1 (ko) * 2005-12-28 2007-05-23 한국생명공학연구원 위암 진단 마커로서의 Ｍａｃ-2ＢＰ
JP4815589B2 (ja) * 2006-02-08 2011-11-16 国立大学法人弘前大学 膀胱癌の悪性度の検査方法
KR100767018B1 (ko) * 2006-05-15 2007-10-12 한국생명공학연구원 종양 발생 및 전이에 관여하는 당단백질의 당쇄 변화를측정하는 방법
JP2009014433A (ja) * 2007-07-03 2009-01-22 Yokohama City Univ 固体支持体において生体分子の修飾を分析する方法
WO2009048196A1 (en) * 2007-10-08 2009-04-16 Korea Research Institute Of Bioscience And Biotechnology An identification method of glycoproteins using a specific lectin precipitation
CN101571549B (zh) * 2008-04-30 2013-08-14 上海泽润生物科技有限公司 Vero细胞HCP检测试剂盒及其应用
JP5212893B2 (ja) * 2008-05-09 2013-06-19 住友ベークライト株式会社 Ｎ結合型糖鎖を利用した膵臓癌の診断方法
KR20090131745A (ko) * 2008-06-19 2009-12-30 한국생명공학연구원 특정 렉틴 친화 크로마토그래피를 이용하여 혈액 유래당단백질을 동정하는 방법
KR20120082429A (ko) * 2009-09-18 2012-07-23 미쓰비시 가가꾸 가부시키가이샤 간세포암 마커
KR101207797B1 (ko) 2009-10-09 2012-12-04 한국생명공학연구원 다중렉틴을 이용한 체액 유래 단백질 동정 방법 및 이 방법에 의하여 탐지된 간암 바이오마커
CN101852804B (zh) * 2010-03-29 2013-06-12 中国医学科学院病原生物学研究所 Gdf15蛋白的抗体的新用途
EP3575799B1 (de) 2011-03-24 2020-06-24 Keio University Marker zur bestimmung der empfindlichkeit gegen ein antikrebsmittel
KR101219516B1 (ko) * 2012-03-27 2013-01-11 한국기초과학지원연구원 암 진단용 펩티드 마커 및 이를 이용한 암 진단방법
EP2932272A4 (de) * 2012-10-17 2016-09-14 Ma Runlin Z Shon als prognostischer biomarker für krebs und als prädiktor der reaktion auf eine endokrintherapie
CN103487588B (zh) * 2013-09-18 2015-01-14 福建医科大学附属第一医院 Galectin-4蛋白在制备巨大肝癌术后预后评估试剂盒中的应用
KR101559101B1 (ko) * 2013-11-28 2015-10-12 한국기초과학지원연구원 혈액유래 암 진단용 펩티드 마커 및 이를 이용한 암 진단방법
CN104267185B (zh) * 2014-09-12 2016-05-18 范飞舟 检测肿瘤的试剂盒及其专用识别n-乙酰氨基葡萄糖的物质
CN104198707B (zh) * 2014-09-12 2016-09-14 范飞舟 N-乙酰氨基葡萄糖在制备检测肿瘤的试剂盒中的应用
CN104502611A (zh) * 2014-12-25 2015-04-08 西安交通大学医学院第一附属医院 一种蛋白质糖基化亚型的检测试剂盒及其检测方法
JP6799226B2 (ja) * 2015-07-24 2020-12-16 公立大学法人名古屋市立大学 骨髄線維症の状態の診断を補助する方法、予後の予測を補助する方法、及び治療効果のモニター方法、並びにそれらの方法に用いるマーカー及び装置
KR101648926B1 (ko) * 2015-09-03 2016-08-18 주식회사 아스타 생물학적 복합 유체 내의 n-글라이칸을 분석하는 방법
CN105527444B (zh) * 2015-12-21 2018-08-24 深圳华康生物医学工程有限公司 抑制素b的酶联免疫检测试剂盒及抑制素b测试方法
CN105628934B (zh) * 2016-02-05 2017-07-28 西北大学 特定凝集素组合在制备用以鉴别肺癌类型及分期的测试载体方面的用途
JP6834747B2 (ja) 2016-05-18 2021-02-24 東ソー株式会社 肺癌を検出する方法及び検出用キット
US10753936B2 (en) 2016-07-22 2020-08-25 Van Andel Research Institute Method of detecting the level of a glycan
EP3692371A4 (de) * 2017-10-04 2021-06-09 Agency for Science, Technology and Research Biomarker zur erkennung und charakterisierung von krebs
WO2020004244A1 (ja) * 2018-06-26 2020-01-02 富士フイルム和光純薬株式会社 膵臓癌の判定用マーカー
CN109682974A (zh) * 2018-12-29 2019-04-26 江苏先思达生物科技有限公司 一种胰腺癌检测试剂及其在胰腺癌检测中的应用
US11981729B2 (en) 2019-01-31 2024-05-14 Agency For Science, Technology And Research Method
JP7376048B2 (ja) * 2019-11-15 2023-11-08 富士フイルム株式会社 大腸癌の診断を補助する方法、キット及びバイオマーカー

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2579497B2 (ja) * 1987-09-07 1997-02-05 オリエンタル酵母工業株式会社 肝臓疾患診断剤
CA1313496C (en) * 1988-04-29 1993-02-09 James Wilson Dennis Diagnostic method to screen tumors
FI971124A0 (fi) * 1997-03-18 1997-03-18 Locus Genex Oy Metod foer diagnostisering av magcancer
KR100277660B1 (ko) * 1997-12-27 2001-01-15 박호군 N-아세틸 글루코사민 전이효소ⅲ의 활성도 측정방법 및 그 측정용 킷트
KR100263313B1 (ko) * 1998-02-11 2000-08-01 김철호 새로운 인간 n-아세틸글루코사민전이효소v 유전자 및 이를 이용한 활성형 효소의 제조방법
US6465181B2 (en) * 1999-03-25 2002-10-15 Abbott Laboratories Reagents and methods useful for detecting diseases of the prostate
KR100377378B1 (ko) * 1999-12-28 2003-03-28 다이알렛 리미티드 세포외 사이클릭 아데노신 모노포스페이트-의존성 프로테인 카인나아제를 이용한 extraPKA의 정량방법
WO2001062912A2 (en) 2000-02-24 2001-08-30 University Of Guelph Method of modulating glycosylation pathways
ES2300325T3 (es) * 2000-04-20 2008-06-16 St Vincent's Hospital Sydney Limited Ensayo diagnostico que implica la citoquina 1 inhibitoria de macrofagos (mc1).
KR20020090720A (ko) * 2001-05-29 2002-12-05 메타볼랩(주) 전이성 암의 진단방법 및 전이성 암의 진단용ｒｔ―ｐｃｒ 반응 전혼합물
KR100475642B1 (ko) * 2001-12-29 2005-03-10 한국생명공학연구원 암 발생 및 전이에 관여하는 단백질의 당쇄 변화를측정하여 암을 진단하는 방법 및 이를 이용한 진단킷트

Also Published As

Publication number Publication date
EP1466179A4 (de) 2006-09-20
JP4621268B2 (ja) 2011-01-26
ATE410690T1 (de) 2008-10-15
KR100475642B1 (ko) 2005-03-10
WO2003060522A1 (en) 2003-07-24
US7622261B2 (en) 2009-11-24
US20050214878A1 (en) 2005-09-29
EP1972939B1 (de) 2011-01-26
KR20030059852A (ko) 2003-07-12
JP2008249716A (ja) 2008-10-16
EP1466179B1 (de) 2008-10-08
JP2005515440A (ja) 2005-05-26
ATE497170T1 (de) 2011-02-15
JP4184282B2 (ja) 2008-11-19
EP1972939A1 (de) 2008-09-24
DE60239089D1 (de) 2011-03-10
US8084218B2 (en) 2011-12-27
CN1610831A (zh) 2005-04-27
AU2002359058B2 (en) 2007-04-05
EP1466179A1 (de) 2004-10-13
CN100451655C (zh) 2009-01-14
US20100099121A1 (en) 2010-04-22
AU2002359058A1 (en) 2003-07-30

Similar Documents

Publication Publication Date Title
DE60229296D1 (de) Verfahren zur diagnose von krebserkrankungen durch messung der mit der tumorbildung und metastase in zusammenhang stehenden änderungen der glykosylierung von prostate-derived factor (pdf).
ATE470723T1 (de) Genexpressionsmarker für die prognose von brustkrebs
DE69928809D1 (de) Differentielle diagnose von neurodegeneration
ATE440536T1 (de) Verfahren zur diagnose, behandlung und prävention von knochenverlust
DE60233949D1 (de) Diagnostische marker für schlaganfall und hirntrauma sowie verfahren zur verwendung davon
DE60326567D1 (de) Diagnose von hepatozellulärem karzinom
MXPA06012232A (es) Uso del patron proteogenomico del plasma para diagnostico, clasificacion, prediccion de respuesta a la terapia y comportamiento clinico, estratificacion de la terapia y monitoreo de enfermedad, en malignidades hematologicas.
WO2003046808A3 (en) Method for distinguishing benign and malignant nodules
DE60211849D1 (de) Verfahren zur Identifizierung von Liganden eines biologischen Substrats
WO2002064015A3 (en) Pin1 as a marker for prostate cancer
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE602004017317D1 (de) Verwendung der proteine proteinase 3 (prn3) und leukozyten elastatse inhibitor (ileu) als marker für kolorektale karzinome
DE60329861D1 (de) Neue, auf der antigen-antikörper-reaktion beruhende sondenplatte sowie reagenzienkit und verfahren mit verwendung der sondenplatte
DE602005027065D1 (de) Verwendung neuartiger biomarker zum nachweis von hodenkrebs in situ und abgeleiteten krebserkrankungen in menschlichen proben
DE50007635D1 (de) Verfahren zur diagnose von sjögren-syndrom
ATE409002T1 (de) Gerät für prostatekrebsdiagnose
ATE534037T1 (de) Verwendung des proteins asc als marker für brustkrebs
DE602004013554D1 (de) Verbindungen und verfahren zur diagnose von prostatakrebs
ATE353544T1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE437368T1 (de) Verfahren zum prüfen von mit wt1-verbundenen krankheiten
BR0010558A (pt) Métodos para prognosticar e/ou diagnosticar o risco de câncer gástrico
BR0115689A (pt) Análise de expressão de inibidor de diferenciação de ácidos nucléicos e polipeptìdeos úteis na diagnose e tratamento de câncer da próstata
DE60235568D1 (de) Diagnoseverfahren für krebs, das durch den nachweis der deletion des g-csf-exons 3 gekennzeichnet ist
DE602006017228D1 (de) Verfahren zur diagnose von tumoren durch messung des niveaus von apolipoprotein a-iv
DE69833546D1 (de) Verfahren zur bestimmung des procarboxypetidase-a- und carboxypeptidase-a-spiegels in biologischen flüssigkeiten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition